Official recall notice

FDA DrugClass INotable

FDA Recall: Kian Pee Wan Capsules, 30-count bottles

Recall date
2026-08-19
Category
Drug
FDA class
Class I

Why it was recalled

Hazard

Marketed Without an Approved NDA/ANDA: Product contains undeclared drug ingredients dexamethasone and cyproheptadine.

Recommended action

What to do

71 bottles

Product description

Marketed Without an Approved NDA/ANDA: Product contains undeclared drug ingredients dexamethasone and cyproheptadine.

Verify with the official notice →
Share:

Related Recalls

2026-08-19 · FDA_DRUG
FDA Recall: Glutathione (MDV), 200 mg/mL, 30 mL vial, each mL contains Glutathione 200 mg, Ascorbic Acid 20 mg,
Victory Medical Center Pharmacy
2026-08-19 · FDA_DRUG
FDA Recall: TADALAFIL USP, 0.500 KG, 0.500KG(500gm)-bag, Rx only, "For Prescription Compounding Only", Shoolin
Shoolin Pharma Chem LLP
2026-08-19 · FDA_DRUG
FDA Recall: TADALAFIL USP, 0.100 KG, 0.1KG(100gm)-bag, Rx only, "For Prescription Compounding Only", Shoolin Ph
Shoolin Pharma Chem LLP
2026-08-19 · FDA_DRUG
FDA Recall: SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Onl
Apollo Care, LLC